Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 1;318(3):F754-F762.
doi: 10.1152/ajprenal.00566.2019. Epub 2020 Feb 10.

Urethral dysfunction in a rat model of chemically induced prostatic inflammation: potential involvement of the MRP5 pump

Affiliations

Urethral dysfunction in a rat model of chemically induced prostatic inflammation: potential involvement of the MRP5 pump

Eduardo C Alexandre et al. Am J Physiol Renal Physiol. .

Abstract

Prostate inflammation (PI) is a clinical condition associated with infection and/or inflammation of the prostate. It is a common disease frequently associated to lower urinary tract (LUT) symptoms. The urethra is an understudied structure in the LUT and plays a fundamental role in the urinary cycle. Here, we proposed to evaluate the effect of PI on the urethra tissue. Male Sprague-Dawley rats were used, and PI was induced by formalin injection into the ventral lobes of the prostate. The pelvic urethra at the prostatic level was harvested for histological analysis, contraction (electrical field stimulation and phenylephrine), and relaxation (sodium nitroprusside/MK-571) experiments. Various gene targets [cytochrome c oxidase subunit 2, transforming growth factor-β1, interleukin-1β, hypoxia-inducible factor-1α, α1A-adrenoceptor, inositol 1,4,5-trisphosphate receptor type 1, voltage-gated Ca2+ channel subunit-α1D, neuronal nitric oxide synthase, soluble guanylyl cyclase, phosphodiesterase 5A, protein kinase CGMP-dependent 1, and multidrug resistance-associated protein 5 (MRP5; ATP-binding cassette subfamily C member 5)] were quantified, and cGMP levels were measured. No histological changes were detected, and functional assays revealed decreased contraction and increased relaxation of urethras from the PI group. The addition of MK-571 to functional assays increased urethral relaxation. Genes associated with inflammation were upregulated in urethras from the PI group, such as cytochrome oxidase c subunit 2, transforming growth factor-β1, interleukin-1β, and hypoxia-inducible factor-1α. We also found increased expression of L-type Ca2+ channels and the neuronal nitric oxide synthase enzyme and decreased expression of the MRP5 pump. Finally, cGMP production was enhanced in urethral tissue of PI animals. The results indicate that PI is associated with proinflammatory gene expression in the urethra without histologically evident inflammation and that PI produces a dysfunctional urethra and MRP5 pump downregulation, which results in cGMP accumulation inside the cell. These findings would help to better understand LUT dysfunctions associated with PI and the role of MRP pumps in the control of LUT function.

Keywords: cGMP; electrical field stimulation; multidrug resistance-associated protein 5; phenylephrine; prostatitis.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest, financial or otherwise, are declared by the author(s).

Figures

Fig. 1.
Fig. 1.
Sham (A and C) and prostate inflammation (PI; B and D) urethral transverse sections (8 µm) stained with hematoxylin and eosin. Images were captured using ×10 eyepieces with ×4 and ×10 objectives (n = 4−5).
Fig. 2.
Fig. 2.
Contraction responses to electrical field stimulation (1–32 Hz; A) and phenylephrine (PE; C) with representative original traces (B and D, respectively) in the urethra from sham and prostate inflammation (PI) groups. Data are presented as means ± SE; n = 6–7. *P < 0.05 compared with the sham group (Student’s t test).
Fig. 3.
Fig. 3.
Sodium nitroprusside (SNP)-induced relaxation (1, 10, and 100 μM) in rat urethras from the sham and prostate inflammation (PI) groups in the absence or presence of MK-571 (20 μM; A). Relaxations were calculated relative to the maximal changes from the contraction produced by phenylephrine (PE; 10 μM) in each urethral ring, which was taken as 100%. B: representative traces. Data are presented as means ± SE; n = 10. *P < 0.05 and **P < 0.01 compared with the sham group (one-way ANOVA followed by a Tukey test).
Fig. 4.
Fig. 4.
mRNA expression of cytochrome c oxidase subunit 2 (MTCO2, COX2; A), transforming growth factor-β1 (TGFB1, TGF-β1; B), interleukin-1β (IL1B, IL-1β; C), and hypoxia-inducible factor-1α (HIF1A, HIF-1α; D) in the urethra from sham and prostate inflammation (PI) groups. The mRNA expression level of each gene was normalized to the β-actin (ACTB) expression level. Data are presented as means ± SE; n = 7. *P < 0.05 and **P < 0.01 compared with the sham group (Student’s t test).
Fig. 5.
Fig. 5.
mRNA expressions of α1A-adrenoceptor (ADRA1A, α1A-AR; A), inositol 1,4,5-trisphosphate receptor type 1 (ITPR1, IP3R; B), voltage-gated Ca2+ channel subunit-α1D (CACNA1D, L-type Ca2+ channel; C), neuronal nitric oxide synthase (NOS2, nNOS; D), soluble guanylate cyclase (GUCY1B2, sGC; E), phosphodiesterase 5A (PDE5A, PDE5; F), protein kinase CGMP-dependent 1 (PRKG1, PKG; G), and ATP-binding cassette subfamily C member 5 [ABCC4, multidrug resistance-associated protein 5 (MRP5); H] in the urethra from sham and prostate inflammation (PI) groups. The mRNA expression level of each gene was normalized to the β-actin (ACTB) expression level. Data are presented as means ± SE; n = 6–7. *P < 0.05 compared with the sham group (Student’s t test).
Fig. 6.
Fig. 6.
cGMP content in urethral tissues from sham and prostate inflammation (PI) groups. Tissues were stimulated with sodium nitroprusside (SNP; 10 μM). Data are presented as means ± SE; n = 6. ***P < 0.001 compared with the sham group (Student’s t test).

Similar articles

Cited by

References

    1. Alexandre EC, Calmasini FB, de Oliveira MG, Silva FH, da Silva CPV, André DM, Leonardo FC, Delbin MA, Antunes E. Chronic treatment with resveratrol improves overactive bladder in obese mice via antioxidant activity. Eur J Pharmacol 788: 29–36, 2016. doi:10.1016/j.ejphar.2016.06.017. - DOI - PubMed
    1. Alexandre EC, Calmasini FB, Sponton ACDS, de Oliveira MG, André DM, Silva FH, Delbin MA, Mónica FZ, Antunes E. Influence of the periprostatic adipose tissue in obesity-associated mouse urethral dysfunction and oxidative stress: effect of resveratrol treatment. Eur J Pharmacol 836: 25–33, 2018. doi:10.1016/j.ejphar.2018.08.010. - DOI - PubMed
    1. Alexandre EC, de Oliveira MG, Campos R, Kiguti LR, Calmasini FB, Silva FH, Grant AD, Yoshimura N, Antunes E. How important is the α1-adrenoceptor in primate and rodent proximal urethra? Sex differences in the contribution of α1-adrenoceptor to urethral contractility. Am J Physiol Renal Physiol 312: F1026–F1034, 2017. doi:10.1152/ajprenal.00013.2017. - DOI - PubMed
    1. Alexandre EC, Leiria LO, Silva FH, Mendes-Silvério CB, Calmasini FB, Davel APC, Mónica FZ, De Nucci G, Antunes E. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770. J Pharmacol Exp Ther 349: 2–9, 2014. doi:10.1124/jpet.113.211029. - DOI - PubMed
    1. Anderson RU, Weller C. Prostatic secretion leukocyte studies in non-bacterial prostatitis (prostatosis). J Urol 121: 292–294, 1979. doi:10.1016/S0022-5347(17)56758-0. - DOI - PubMed

Publication types